Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-03-19

Clinical Trial Update: The Effectiveness of 18F-fluorocholine Positron Emission Tomography (PET) in Detecting, Staging and Following-up Prostate Cancer

View source ↗

Summary

Clinical trial evaluating the effectiveness of 18F-fluorocholine PET in detecting, staging, and following up prostate cancer; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 18F-Fluorocholine (fluorocholine radiotracer)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Prostate Cancer | Status: UNKNOWN